The US Centers for Disease Control and Prevention said it has concluded that the known and potential benefits of the Janssen COVID-19 Vaccine outweigh its known and potential risks in individuals 18 years of age and older.
Johnson & Johnson Covid vaccinations were put on hold amid blood clot concerns. (File)
Washington:
Johnson & Johnson Covid vaccinations can restart, US health regulators said Friday, after the shots’ rollout was paused due to worries over blood clotting.
“We have concluded that the known and potential benefits of the Janssen COVID-19 Vaccine outweigh its known and potential risks in individuals 18 years of age and older,” said a statement from the Centers for Disease Control and Prevention.
(Except for the headline, this story has not been edited by our staff and is published from a syndicated feed.)